CORRECTION article

Front. Mol. Biosci., 13 April 2022

Sec. Molecular Diagnostics and Therapeutics

Volume 9 - 2022 | https://doi.org/10.3389/fmolb.2022.901322

Corrigendum: Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis

  • 1. Department of Anesthesiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China

  • 2. Department of Pharmacology, Shantou University Medical College, Shantou, China

Article metrics

View details

2

Citations

1,3k

Views

876

Downloads

There is an error in the Funding statement. The correct number for “the National Natural Science Foundation of China” is “ 81473215 and 81870276”.

Additionally, in the original article, there was a mistake in “Figures 24” as published. The problem was caused by the incomplete uploading of some figures in the process of uploading revised manuscripts and figures before publication. We did not carefully check it, which led to the error when publishing the article. The correct figures appear below:

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

FIGURE 2

FIGURE 3

FIGURE 4

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

sevoflurane, myocardial ischemia reperfusion, hypoxia and reoxygenation, P2X7, NLRP3, pyroptosis

Citation

Wu J, Cai W, Du R, Li H, Wang B, Zhou Y, Shen D, Shen H, Lan Y, Chen L, Zheng X, Huang D and Shi G (2022) Corrigendum: Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis. Front. Mol. Biosci. 9:901322. doi: 10.3389/fmolb.2022.901322

Received

21 March 2022

Accepted

22 March 2022

Published

13 April 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

9 - 2022

Updates

Copyright

*Correspondence: Ganggang Shi,

This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics